GRI Bio

United States
San Diego, California, United States, 92037

Company profile

GRI Bio company profile

GRI Bio is a biotechnology company that develops therapies to treat inflammatory diseases. Its cell-based therapies are developed to treat liver disease and autoimmunity deficiencies by targeting the regulation of NKT cells.

Business identity

Phone number
(619) 400-1171
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$26.9M
Last funding
Post IPO Equity / $8M / 2025-12-11
Last equity funding
Post IPO Equity / $8M
Investors
1
Lead investors
1
Founders
1
Articles
103
Exited on
2023-04-24

Founders and investors

Founders

Marc Hertz

Lead investors

National Science Foundation

Investors

National Science Foundation